effect overlay
activetrials
Stroke
Stroke
ALNylam

A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Intrathecally Administered ALN-APP in Patients with Cerebral Amyloid Angiopathy (CAA)

HREC: 2024.264
Principal Investigator: A/Prof Nawaf Yassi
Coordinator contact: David Jackson
Funding: Commercial
Stroke
Stroke
EMU: EMVision Validation Study

Multi-Centre, Prospective, Consecutive, Paired Diagnosis, Diagnostic Performance Study of the EMVision emu™ Brain Scanner in the Detection of Intracranial Haemorrhage in Suspected Stroke Patients (The “EMU” Study)

HREC: 2025.052
Principal Investigator: Dr Anna Balabanski
Coordinator contact:
Funding: Commercial
Active Trials - Other
Traumatic Brain Injury (TBI)
Biomarkers for Brain Concussion

A prospective study of language function following surgical resection of left hemisphere primary brain tumours

HREC: 2015.012
Principal Investigator: A/Prof Sandy Shultz
Coordinator contact:
Funding: Non-Commercial
Active Trials - Other
Peripheral Neuropathy
Argenx BV

A Multicenter Prospective Longitudinal Study of Clinical Outcomes, Disease Course, Health-Related Quality of Life, and Health Care Resource Utilization in Adult Patients With Multifocal Motor Neuropathy (MMN)

HREC: 2024.051
Principal Investigator: Dr Belinda Cruse
Coordinator contact: Callum Hollis
Funding: Commercial
Active Trials - Other
Neuro-Ophthalmology
NODE Registry

Prospective Neuro-Ophthalmology database (NODE) towards developing comprehensive longitudinal outcome measures for neuro-ophthalmic diseases
 

HREC: 2020.336
Principal Investigator: Dr Anthony Fok
Coordinator contact:
Funding: Non-Commercial